Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Ongoing Initiated Jul 31, 2026 (2 months ago)

Optiray Imaging Bulk Package-350 (Ioversol)

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.

Affected NDC 0019-1333-65

Compare with the code on your package — it is the most precise check available.

Drug: Iodine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Optiray 350
Ioversol
NDC 00019-1333
741 mg/mL Injection
Intra-Arterial|intravenous
Liebel-Flarsheim Company LLC Rx
Recalling firm
Liebel-Flarsheim Company LLC
NDC code
0019-1333-65
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
Company announcement
Jul 31, 2026 · FDA notice with lot numbers
FDA recall number
D-0773-2026 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week.

Other Iodine recalls

See all
Class II · Moderate risk

BD PurPrep

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-42 D-0644-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-41 D-0518-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-42 D-0517-2026

Other particulate / foreign matter recalls from 2026

All particulate / foreign matter recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026